참고문헌
- American Joint Committee on Cancer. http://www.cancerstaging.org.
- Banerjee S, Reis-Filho JS, Ashley S, et al (2006). Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clinical Pathology, 59, 729-35. https://doi.org/10.1136/jcp.2005.033043
- Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007). Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer, 109, 1721-8. https://doi.org/10.1002/cncr.22618
- Bloom HJ, Richardson WW (1957). Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer, 11, 359-77. https://doi.org/10.1038/bjc.1957.43
- Carey LA, Perou CM, Livasy CA, et al (2006). Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, 295, 2492-502. https://doi.org/10.1001/jama.295.21.2492
- Cheang MC, Voduc D, Bajdik C, et al (2008). Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res, 14, 1368-76. https://doi.org/10.1158/1078-0432.CCR-07-1658
- Dent R, Hanna WM, Trudeau M, et al (2009). Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res Treat, 115, 423-8. https://doi.org/10.1007/s10549-008-0086-2
- Elias AD (2010). Triple-negative breast cancer: a short review. Am J Clinical Oncol, 33, 637-45. https://doi.org/10.1097/COC.0b013e3181b8afcf
- Fleming ID (2001). AJCC/TNM cancer staging, present and future. J Surg Oncol, 77, 233-6. https://doi.org/10.1002/jso.1101
- Gluz O, Liedtke C, Gottschalk N, et al (2009). Triple-negative breast cancer--current status and future directions. Ann Oncol, 20, 1913-27. https://doi.org/10.1093/annonc/mdp492
- Haffty BG, Yang Q, Reiss M, et al (2006). Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol, 24, 5652-7 https://doi.org/10.1200/JCO.2006.06.5664
- Kurebayashi J, Moriya T, Ishida T, et al (2007) The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. Breast, 16, 72-7. https://doi.org/10.1016/j.breast.2007.07.017
- Kusinska R, Potemski P, Jesionek-Kupnicka D, Kordek R (2005). Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2. Polish J Pathol, 56, 107-10.
- Kwan ML, Kushi LH, Weltzien E, et al (2009). Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res, 11, 31.
- Lara-Medina F, Perez-Sanchez V, Saavedra-Perez D, et al (2011). Triple-negative breast cancer in hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer, 117, 3658-69. https://doi.org/10.1002/cncr.25961
- Lee JA, Kim KI, Bae JW, et al (2010). Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival. Breast Cancer Res Treat, 123, 177-87. https://doi.org/10.1007/s10549-010-0998-5
- Lin C, Chien SY, Chen LS, et al (2009a). Triple negative breast carcinoma is a prognostic factor in Taiwanese women. BMC Cancer, 9, 192. https://doi.org/10.1186/1471-2407-9-192
- Lin Y, Yin W, Yan T, et al (2009b). Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients. BMC Cancer, 9, 342. https://doi.org/10.1186/1471-2407-9-342
- Lund MJ, Trivers KF, Porter PL, et al (2009). Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Research & Treatment, 113, 357-70. https://doi.org/10.1007/s10549-008-9926-3
- Millikan RC, Newman B, Tse CK, et al (2008). Epidemiology of basal-like breast cancer. Breast Cancer Res Treat, 109, 123-39. https://doi.org/10.1007/s10549-007-9632-6
- O'Shaughnessy J, Osborne C, Pippen JE, et al (2011). Iniparib plus chemotherapy in metastatic triple-negative breast cancer. New England J Med, 364, 205-14. https://doi.org/10.1056/NEJMoa1011418
- Plummer R (2011). Poly (ADP-ribose) polymerase inhibition: a new direction for BRCA and triple-negative breast cancer? Breast Cancer Research, 13, 218. https://doi.org/10.1186/bcr2877
- Rakha EA, El-Sayed ME, Green AR, et al (2007). Prognostic markers in triple-negative breast cancer. Cancer, 109, 25-32. https://doi.org/10.1002/cncr.22381
- Rodriguez-Pinilla SM, Sarrio D, Honrado E, et al (2006). Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res, 12, 1533-9. https://doi.org/10.1158/1078-0432.CCR-05-2281
- Saip P, Cicin I, Eralp Y, et al (2009). Identification of patients who may benefit from the prophylactic cranial radiotherapy among breast cancer patients with brain metastasis. J Neurooncol, 93, 243-51. https://doi.org/10.1007/s11060-008-9769-0
- Tan DS, Marchio C, Jones RL, et al (2008). Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Treat, 111, 27-44. https://doi.org/10.1007/s10549-007-9756-8
- Thike AA, Iqbal J, Cheok PY, et al (2010). Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers. Am J Surgical Pathol, 34, 956-64. https://doi.org/10.1097/PAS.0b013e3181e02f45
- Tischkowitz M, Brunet JS, Begin LR, et al (2007). Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. BMC Cancer, 7, 134. https://doi.org/10.1186/1471-2407-7-134
- Yao-lung K, Dar-ren C, Tsai-wang C (2011). Clinicopathological features of triple-negative breast cancer in Taiwanese women. Int J Clinical Oncol, 16, 500-5. https://doi.org/10.1007/s10147-011-0211-9
- Yin WJ, Lu JS, Di GH, et al (2009). Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients. Breast Cancer Res Treat, 115, 325-33. https://doi.org/10.1007/s10549-008-0096-0
피인용 문헌
- Efficacy and mechanism of action of Deguelin in suppressing metastasis of 4T1 cells vol.30, pp.7, 2013, https://doi.org/10.1007/s10585-013-9585-6
- There Is No Association between MicroRNA Gene Polymorphisms and Risk of Triple Negative Breast Cancer in a Chinese Han Population vol.8, pp.3, 2013, https://doi.org/10.1371/journal.pone.0060195
- Effect of Lymphangiogenesis and Lymphovascular Invasion on the Survival Pattern of Breast Cancer Patients vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6287
- Clinico-Morphological Profile and Receptor Status in Breast Cancer Patients in a South Indian Institution vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7839
- Outcomes of Triple-Negative Versus Non-Triple-Negative Breast Cancers Managed with Breast-Conserving Therapy vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2577
- High Levels of BCOX1 Expression Are Associated with Poor Prognosis in Patients with Invasive Ductal Carcinomas of the Breast vol.9, pp.1, 2014, https://doi.org/10.1371/journal.pone.0086952